top of page

We have all been told at some point that it's important for everyone to get vaccinated in order to protect those who can't.  We are given the image of a sick, immunocompromised child and told that this child will not be able to attend school with their peers, or go out into the community unless we all get vaccinated.  Only then will we reach "heard immunity", protecting the child from illness by forming a sort of cocoon of protection around them.  This idea sounds great in theory.  I even fell for it after having my son.  I dutifully went out and got my flu shot to protect my precious new baby boy.  However, there are several holes in the theory. 


Screenshot (304).png

Vaccine Failure

The topic of vaccine failure has become increasingly popular over the last few years.  We were told that vaccines would be the only way out of the pandemic.  We were told that it was a "pandemic of the unvaccinated".  We were told if we got vaccinated we would not get sick and that we would be protecting others from getting sick.  I think it is safe to say that none of those things are true.  It has a lot of people talking about what a failure these vaccines are.  People rightfully feel as though they were lied to.  But vaccine failure didn't start with the coivd vaccines. 

An article from Medical University Vienna describes vaccine failure
"There are 2 major factors responsible for vaccine failures, the first is vaccine-related such as failures in vaccine attenuation, vaccination regimes or administration. The other is host-related, of
which host genetics, immune status, age, health or nutritional status can be associated with primary or secondary vaccine failures. The first describes the inability to respond to primary vaccination, the latter is characterized by a loss of protection after initial effectiveness. "
The article states that, "about 2-10% of healthy individuals fail to mount antibody levels to routine vaccines."

Although it varies, some diseases such as measles need 95% vaccination rates in order to reach heard immunity.  That means if every person that could get vaccinated did
 we likely still would not reach herd immunity.

Immunized People Getting Whooping Cough

June 12, 2014
By Joanne Faryon / Investigative Reporter, KPBS Staff

Of the 621 people who contracted the illness, 85 percent had all their preventative shots — calling into question the efficacy of the vaccine.

The Re-Emergence of Measles in Developed Countries: Time to Develop the Next-Generation Measles Vaccines?

January 5, 2012
Gregory A. Poland, MD, MACP, Editor-in-Chief, VACCINE and Robert M. Jacobson, MD, FAAP, Professor of Pediatrics

Multiple studies demonstrate that 2–10% of those immunized with two doses of measles vaccine fail to develop protective antibody levels, and that immunity can wane over time and result in infection (so-called secondary vaccine failure) when the individual is exposed to measles. In an October 2011 outbreak in Canada, over 50% of the 98 individuals had received two doses of measles vaccine.

United States ex rel. Krahling v. Merck & Co.

August 27, 2010
Nstural News

Relators Krahlillg and WlochoWBki were OOlpioyed as virologists in the Merck lub
that perlOOne<llhis fraudulent efficacy testing. They witnessed fimthand the improper 'esting
and data falsification. in v.iJjcll Mcrc.k engaged to artificially ififuue the vaeclne's efficacy
findings, In fad, they were pressured by their Merck superiors and senior Merck ma.nag«nent to
participate in the fraud and subsequent cover-up.

Nearly 200 people in Texas detention facilities have contracted mumps

March 1, 2019
The Texas Tribune BY MARISSA EVANS

-Nearly 200 people have contracted mumps at detention facilities across Texas since October, according to a state health agency. - “there has been no reported transmission to the community.” -She added that the state doesn’t know the vaccination status of detained migrant adults or the children who entered the U.S. with them but that “all unaccompanied minors are vaccinated when they are detained.”

The 112-Year Odyssey of Pertussis and Pertussis Vaccines-Mistakes Made and Implications for the Future

September 25, 2019
James D Cherry

In the last 13 years, major pertussis epidemics have occurred in the United States, and numerous studies have shown the deficiencies of DTaP vaccines, including the small number of antigens that the vaccines contain and the type of cellular immune response that they elicit. The type of cellular response a predominantly, T2 response results in less efficacy and shorter duration of protection. Because of the small number of antigens (3-5 in DTaP vaccines vs >3000 in DTwP vaccines), linked-epitope suppression occurs. Because of linked-epitope suppression, all children who were primed by DTaP vaccines will be more susceptible to pertussis throughout their lifetimes, and there is no easy way to decrease this increased lifetime susceptibility.

Vaccinated child had Maine’s first case of measles in 2 years, say health officials

May 21, 2019

“The child is vaccinated, did not have any serious complications, and is fully recovered from the disease,”

The Pink Book

Centers for Disease Control

-From 1985 through 1988, 68% of cases in school-aged children (age 5 to 19 years) occurred among those who had been appropriately vaccinated -In 2019, 13 outbreaks of measles were reported, accounting for 663 cases; six were associated with underimmunized close-knit communities -The original Edmonston B vaccine was withdrawn in 1975 because of a relatively high frequency of fever and rash in recipients. -Approximately 2% to 7% of children who receive only 1 dose of MMR vaccine fail to respond to it, i.e., they experience primary vaccine failure. MMR vaccine failure can occur because of passive antibody in the vaccine recipient, immaturity of the immune system, damaged vaccine, or other reasons. -Most adverse events reported following MMR vaccination (such as fever and rash) are attributable to the measles component. - “During the 1989 -1991 measles resurgence, incidence rates for infants were more than twice as high as those in any other age group. The mothers of many infants who developed measles were young, and their measles immunity was most often due to vaccination rather than infection with wild virus. As a result, a smaller amount of antibody was transferred across the placenta to the fetus, compared with antibody transfer from mothers who had higher antibody titers resulting from wild-virus infection. The lower quantity of antibody [in the vaccine] resulted in immunity that waned more rapidly, making infants susceptible at a younger age than in the past.”

The relationship between mucosal immunity, nasopharyngeal carriage, asymptomatic transmission and the resurgence of Bordetella pertussis [version 1; peer review: 2 approved]

August 25, 2017
Christopher J. Gill Pejman Rohani, Donald M Thea

In conclusion, the preponderance of available evidence now suggests that the list of plausible explanations for the resurgence of pertussis in the aP vaccination era goes beyond the “poor persistence” and “waning efficacy” of these vaccines to include an additional and likely pivotal factor: “lack of sterilizing mucosal immunity”. the current burden of disease is not well explained by the disease that is observed but implies asymptomatic chains of transmission; aP vaccination, or passively acquired antibodies resulting from aP vaccination, prevents symptomatic disease in animals but does not block infections; transmission readily occurs between asymptomatic aP-vaccinated but infected animals to uninfected animals in close physical proximity;

Fifty-one percent of cases of patients in a 1998/1999 mumps outbreak had at least one MMR vaccination, indicating their effectiveness may be overestimated.

July 1, 2005
Richard Harling, Joanne M White, Mary E Ramsay, Karen F Macsween, Corry van den Bosch

The observed effectiveness of any MMR vaccination adjusted for age, sex and general practice was 69%. - Two doses of vaccine were more effective (88%) than a single dose (64%).

The Navy's fighting to get a rare viral mumps outbreak under control after it stranded a US warship at sea

March 29, 2019
Business INSIDER Ryan Pickrell

-27 sailors and Marines aboard the dock landing ship USS Fort McHenry have been diagnosed with parotitis, which the Navy described in a statement earlier this month as a "viral infection which has symptoms similar to mumps." -Viral parotitis is an infection of the saliva glands on either side of the face that's typically caused by the mumps. -“The Navy’s position is that vaccines are effective at reducing the incidence and severity of vaccine-preventable diseases,” BUMED told BI. Unfortunately, “the mumps portion of the measles, mumps, and rubella (MMR) vaccine is the least effective of the three components, providing 88% effectiveness after completion of the two dose series”

Shedding/Vaccine Derived Disease

  • Due to the concern for transmission of vaccine virus, vaccine recipients should attempt to avoid, whenever possible, close association with susceptible high-risk individuals for up to 6 weeks following vaccination.

  • .Vaccine recipients should avoid close contact with high-risk individuals susceptible to varicella due to possible risk of transmission. Varicella vaccine virus transmission may occur between vaccine recipients and contacts susceptible to varicella including healthy individuals.

  •  Other reported adverse reactions in all age groups include: varicella-like rash (injection site) and varicella-like rash (generalized).

  • VARIVAX may establish latency of varicella zoster virus in immunocompetent individuals, with the potential for later development of herpes zoster.

  • Measles inclusion body encephalitis  (MIBE), pneumonitis, and death as a direct consequence of disseminated measles vaccine virus infection have been reported in immunocompromised individuals inadvertently vaccinated with measles-containing vaccine. In this population, disseminated mumps and rubella vaccine virus infection have also been reported.

  • The following adverse reactions include those identified during clinical trials or reported during post-approval use of M-M-R II vaccine or its individual components.

    • atypical measles​

    • measles inclusion body encephalitis (MIBE)

    • measles-like rash

From The Insert

Shedding Studies Shedding of vaccine viruses within 28 days of vaccination with FluMist was evaluated in (1) multi-center Study MI-CP129 which enrolled healthy individuals 6 through 59 months of age (N = 200); and (2) multi-center Study FM026 which enrolled healthy individuals 5 through 49 years of age (N = 344). In each study, nasal secretions were obtained daily for the first 7 days and every other day through either Day 25 and on Day 28 or through Day 28. In Study MI-CP129, individuals with a positive shedding sample at Day 25 or Day 28 were to have additional shedding samples collected every 7 days until culture negative on 2 consecutive samples. Results of these studies are presented in Table 5

Screenshot (303).png

Measles outbreak in a fully immunized secondary-school population

T L Gustafson, A W Lievens, P A Brunell, R G Moellenberg, C M Buttery, L M Sehulster
Serum samples from 1806 students at two secondary schools were obtained eight days after the onset of the first case. Only 4.1 percent of these students (74 of 1806) lacked detectable antibody to measles according to enzyme-linked immunosorbent assay, and more than 99 percent had records of vaccination with live measles vaccine. We conclude that outbreaks of measles can occur in secondary schools, even when more than 99 percent of the students have been vaccinated and more than 95 percent are immune.

March 26, 1987

Spotlight on measles 2010: Excretion of vaccine strain measles virus in urine and pharyngeal secretions of a child with vaccine associated febrile rash illness, Croatia, March 2010 separator commenting unavailable

B Kaic1 , I Gjenero-Margan1 , B Aleraj1 , T Vilibić-Čavlek2 , M Santak3 , A Cvitković4 , T Nemeth-Blazic1 , I Ivic Hofman4
We describe excretion of measles vaccine strain Schwarz in a child who developed a febrile rash illness eight days after primary immunisation against measles, mumps and rubella. Throat swabs and urine specimens were collected on the fifth and sixth day of illness, respectively. Genotyping demonstrated measles vaccine strain Schwarz (genotype A). If measles and rubella were not under enhanced surveillance in Croatia, the case would have been either misreported as rubella or not recognised at all

June 4, 2010

Shedding of Infectious SARS-CoV-2
Despite Vaccination

Kasen K. Riemersma, DVM, PhD1
; Brittany E. Grogan, MPH2
; Amanda Kita-Yarbro, MPH2
; Peter J.
Halfmann, PhD1
; Hannah E. Segaloff, PhD3
; Anna Kocharian, MS4
; Kelsey R. Florek, MPH, PhD5
; Ryan
Westergaard, MD, PhD6
; Allen Bateman, PhD5
; Gunnar E. Jeppson, BS7
; Yoshihiro Kawaoka, DVM,
; David H. O’Connor, PhD8 ^; Thomas C. Friedrich, PhD1 ^; Katarina M. Grande, MPH2 ^
these results indicate that even asymptomatic, fully
vaccinated people might shed infectious virus.

August 21, 2021

Oral polio vaccinees can continue to shed for at least 13 weeks.

Stephanie B Troy, Leticia Ferreyra-Reyes, Chunhong Huang, Nadim Mahmud, Yu-Jin Lee, Sergio Canizales-Quintero, Harry Flaster, Renata Báez-Saldaña, Lourdes García-García, Yvonne Maldonado
During replication, oral polio vaccine (OPV) can revert to neurovirulence and cause paralytic poliomyelitis. In individual vaccinees, it can acquire specific revertant point mutations, leading to vaccine-associated paralytic poliomyelitis (VAPP). With longer replication, OPV can mutate into vaccine-derived poliovirus (VDPV), which causes poliomyelitis outbreaks similar to those caused by wild poliovirus. Our real-time PCR assay was able to detect small amounts of OPV in both stool and sewage and to distinguish nonrevertant and revertant serotypes and demonstrated that OPV continues to circulate at least 13 weeks after a NID in a Mexican population routinely immunized with IPV.

March 16, 2011

Differentiating the wild from the attenuated during a measles outbreak

Lindsay Nestibo, BN RN, Bonita E Lee, MD FRCPC MSC (Epi), Kevin Fonseca, PhD D(ABMM), Jennifer Beirnes, Marcia M Johnson, MD MHSc FRCPC, Christopher A Sikora, MD MSc MPH CCFP FRCPC
In the midst of a local measles outbreak, a recently immunized child was investigated for a new-onset measles-type rash. Nucleic acid testing identified that a vaccine-type measles virus was being shed in the urine.

April 1, 2012

Case of vaccine-associated measles five weeks post-immunisation, British Columbia, Canada, October 2013

M Murti1 , M Krajden2 , M Petric2 , J Hiebert3 , F Hemming1 , B Hefford4 , M Bigham1 , P Van Buynder1
We describe a case of vaccine-associated measles in a two-year-old patient from British Columbia, Canada, in October 2013, who received her first dose of measles-containing vaccine 37 days prior to onset of prodromal symptoms. Identification of this delayed vaccine-associated case occurred in the context of an outbreak investigation of a measles cluster.

November 15, 2013

Circulating vaccine-derived poliovirus type 2 – Global update

The World Health Organization
In 2020, 959 human cases of circulating vaccine-derived poliovirus type 2 (cVDPV2) and 411 cVDPV2-positive environmental samples were reported globally from 27 countries

March 26, 2021

Of the 13,749 acute flaccid paralysis cases investigated, 58.9% received at least three doses of oral polio vaccine.

Hugo Kavunga Membo, Aaron Mweene, Serge Alain Sadeuh-Mba, Justin Masumu, Riziki Yogolelo, Norbert Ngendabanyikwa, Eddy Sokolua, Fred Sagamiko, Edgar Simulundu, Steve Ahuka, Jean Jacques Muyembe
Of the 13,749 AFP cases investigated, 58.9% received at least three doses of oral polio vaccine (OPV), 7.3% never received OPV, while the status of 18.3% was unknown.

June 22, 2016

Detection of measles vaccine in the throat of a vaccinated child

Florence Morfin a, Anne Beguin b 1, Bruno Lina a, Danielle Thouvenot a
We report here the case of a child presenting with fever 8 days after vaccination with a measles–mumps–rubella vaccine. Measles virus was isolated in a throat swab taken 4 days after fever onset. This virus was then further genetically characterised as a vaccine-type virus.

February 22, 2002

Post-vaccine measles in a child with concomitant influenza, Sicily, Italy, March 2015

F Tramuto1,2 , P Dones3 , C D’Angelo4 , N Casuccio4 , F Vitale1,2
We describe the occurrence of measles in an 18 month-old patient in Sicily, Italy, in March 2015, who received the first dose of a measles-containing vaccine seven days before onset of prodromal symptoms. Measles virus infection was confirmed by PCR and detection of specific immunoglobulin; viral genotyping permitted the confirmation of a vaccine-associated illness.

May 7, 2015

In 2011, there were an extra 47,500 new cases of non-polio acute flaccid paralysis (NPAFP); Clinically indistinguishable from polio paralysis but twice as deadly, the incidence of NPAFP was directly proportional to doses of oral polio received.

Neetu Vashisht, Jacob Puliyel
In 2011, there were an extra 47,500 new cases of NPAFP. Clinically indistinguishable from polio paralysis but twice as deadly, the incidence of NPAFP was directly proportional to doses of oral polio received. Though this data was collected within the polio surveillance system, it was not investigate

April 1, 2012

At the present time, the only poliovirus-caused poliomyelitis cases reported in Brazil and other countries of the Americas are of vaccine etiology.

L H de Oliveira, C J Struchiner
At the present time, the only poliovirus-caused poliomyelitis cases reported in Brazil and other countries of the Americas are of vaccine etiology. Among individuals who had received oral polio vaccine (OPV) from 4 to 40 days before the onset of paralysis, we found a relative risk of 8.88 (95% CI: 4.37-18.03) for VAPP as compared with persons who had not been vaccinated during the same time interval. A major share of VAPP cases were related to children affected by prodromes (fever and gastrointestinal signs and/or symptoms), isolation of vaccine poliovirus type 2, paralysis of the lower limbs, and a mean age of 1 year.

April 1, 2000

Waning Immunity

Waning Tdap Effectiveness in Adolescents

Klein NP, Bartlett J, Fireman B, Baxter R. Waning Tdap Effectiveness in Adolescents. Pediatrics. 2016 Mar;137(3):e20153326. doi: 10.1542/peds.2015-3326. Epub 2016 Feb 5. PMID: 26908667.

Routine Tdap did not prevent pertussis outbreaks. Among adolescents who have only received DTaP vaccines in childhood, Tdap provided moderate protection against pertussis during the first year and then waned rapidly so that litle protection remained 2-3 years after vaccination..

bottom of page